![Evaline Tsai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Evaline Tsai
Private Equity Investor chez
Gigascale Capital
Profil
Evaline Tsai was the founder of Cambridge Cancer Genomics Ltd., founded in 2016, and served as Chief Technology Officer from 2016 to 2018.
Dr. Tsai is currently a Partner at Gigascale Capital Advisors LLC, starting in 2023.
Former positions include Principal at Costanoa Venture Capital Management LLC in 2020 and Senior Associate at Fine Structure Ventures from 2021 to 2022.
Education includes a doctorate from the University of Cambridge conferred in 2019 and an undergraduate degree from Princeton University conferred in 2015.
Postes actifs de Evaline Tsai
| Sociétés | Poste | Début |
|---|---|---|
Gigascale Capital
 Gigascale Capital Investment ManagersFinance Gigascale Capital invests in companies located in the United States. The firm targets companies operating of clean energy, advanced manufacturing, grid infrastructure and physical AI sectors. It participates in pre-seed, seed and early stage capital requirements. | Private Equity Investor | 01/01/2023 |
Anciens postes connus de Evaline Tsai
| Sociétés | Poste | Fin |
|---|---|---|
Fine Structure Ventures
 Fine Structure Ventures Investment ManagersFinance Fine Structure Ventures invests in companies located across the globe. The firm targets companies operating in the fields of disruptive scientific and technological innovation sectors. It provides financing for pre-seed, seed, early and later stage capital requirements. | Analyste en capital-investissement | 01/12/2022 |
Costanoa Venture Capital Management LLC
 Costanoa Venture Capital Management LLC Investment ManagersFinance Costanoa Ventures invests in companies located in the United States primarily in Latin America, Europe, Africa and Australia. The firm targets companies operating in the fields of fintech, data & developer infrastructure, applied AI and cyber & national security. It participates in seed and early stage transactions and also acts as lead investor. | Private Equity Investor | 30/11/2020 |
Cambridge Cancer Genomics Ltd.
 Cambridge Cancer Genomics Ltd. Pharmaceuticals: MajorHealth Technology Provides cancer research and therapy services | Fondateur | 31/12/2018 |
Formation de Evaline Tsai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Costanoa Venture Capital Management LLC
Costanoa Venture Capital Management LLC Investment ManagersFinance Costanoa Ventures invests in companies located in the United States primarily in Latin America, Europe, Africa and Australia. The firm targets companies operating in the fields of fintech, data & developer infrastructure, applied AI and cyber & national security. It participates in seed and early stage transactions and also acts as lead investor. | Finance |
Cambridge Cancer Genomics Ltd.
Cambridge Cancer Genomics Ltd. Pharmaceuticals: MajorHealth Technology Provides cancer research and therapy services | Health Technology |
Fine Structure Ventures
Fine Structure Ventures Investment ManagersFinance Fine Structure Ventures invests in companies located across the globe. The firm targets companies operating in the fields of disruptive scientific and technological innovation sectors. It provides financing for pre-seed, seed, early and later stage capital requirements. | Finance |
Gigascale Capital
Gigascale Capital Investment ManagersFinance Gigascale Capital invests in companies located in the United States. The firm targets companies operating of clean energy, advanced manufacturing, grid infrastructure and physical AI sectors. It participates in pre-seed, seed and early stage capital requirements. | Finance |
